CLINUVEL PHARMACEUTICALS LIMITED — Director's Dealing 2021

Jun 28, 2021

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity CLINUVEL PHARMACEUTICALS LTD ABN 88 089 644 119

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Brenda Shanahan
Date of last notice	13 March 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect Interest (Ordinary Shares)Direct Interest (Unlisted Conditional Performance Rights)
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	1. San Luis Nominees Pty Ltd (trustee for the BrendaShanahan Superannuation Fund)2. Ordinary shares held on behalf of Director by theClinuvel Conditional Performance Rights SchemeTrust (Registered Holder: ACN 108 768 896 PTYLTD)3. Brenda Shanahan Charitable Foundation of which thedirector is a Trustee to the foundation
Date of change	22 to 24 June 2021
No. of securities held prior to change	1. 53,969 Ordinary Shares (San Luis Nominees PtyLtd)2. 125,000 Ordinary shares (Clinuvel ConditionalPerformance Rights Scheme Trust )3. 80,000 Ordinary shares (Brenda ShanahanCharitable Foundation of which the director is aTrustee to the foundation)25,000 Unlisted Conditional Performance Rights
Class	Ordinary Shares
Number acquired	N/A

Number disposed	25,000 Ordinary Shares
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	$691,771.17
No. of securities held after change	1. 53,969 Ordinary Shares (San Luis Nominees PtyLtd)2. 100,000 Ordinary shares (Clinuvel ConditionalPerformance Rights Scheme Trust )3. 80,000 Ordinary shares (Brenda ShanahanCharitable Foundation of which the director is aTrustee to the foundation)25,000 Unlisted Conditional Performance Rights
Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back	On-market sale

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed abovetraded during a+closed period where prior written clearancewas required?	No
If so, was prior written clearance provided to allow the trade toproceed during this period?	n/a
If prior written clearance was provided, on what date was thisprovided?	n/a